Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Endometrial Neoplasms × Celecoxib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Colorectal Neoplasms 29 Breast Neoplasms 23 Lung Neoplasms 22 Carcinoma, Non-Small-Cell Lung 22 Colonic Neoplasms 15 Head and Neck Neoplasms 13 Rectal Neoplasms 12 Prostatic Neoplasms 11 Sarcoma 8 Neoplasm Metastasis 8 Pancreatic Neoplasms 7 Esophageal Neoplasms 7 Adenomatous Polyposis Coli 7 Neoplasms 6 Mouth Neoplasms 6 Glioblastoma 6 Precancerous Conditions 5 Ovarian Neoplasms 5 Melanoma 5 Central Nervous System Neoplasms 5 Unspecified Adult Solid Tumor, Protocol Specific 4 Triple Negative Breast Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 4 Recurrence 4 Neuroblastoma 4 Gliosarcoma 4 Carcinoma 4 Urinary Bladder Neoplasms 3 Oropharyngeal Neoplasms 3 Multiple Myeloma 3

Interventions

Paclitaxel 80 Carboplatin 65 pembrolizumab 62 Cisplatin 25 Bevacizumab 25 Letrozole 21 Surveys and Questionnaires 20 Radiotherapy 20 Doxorubicin 20 olaparib 17 Megestrol Acetate 17 lenvatinib 16 Taxes 16 Specimen Handling 16 dostarlimab 15 Magnetic Resonance Spectroscopy 15 Docetaxel 15 Nivolumab 14 Observation 13 Metformin 13 Blood Specimen Collection 12 durvalumab 11 Medroxyprogesterone Acetate 11 Fulvestrant 11 temsirolimus 10 Indocyanine Green 10 Brachytherapy 10 Biopsy 10 abemaciclib 9 Trastuzumab 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03896113 2020-01-10

CELEBRIDO

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Phase 2 Unknown

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡